d-Glucosamine (DG) was conjugated to a core-cross linked polymeric micelle (CCPM) system equipped with both a near-infrared fluorophore (NIRF) and a gamma emitter (111In). The resultant nano-scale tumor-targeting imaging tracer, 111In-DG-NIRF-CCPM, selectively accumulated in a human epithelial carcinoma A-431 xenograft model in mice. At 24 hrs post injection, the tumor uptake was 2.62 ± 0.80 % of the injected dose per gram of tissue (%ID/g). Tumors were clearly delineated in both single-photon emission computed tomography (SPECT) and optical imaging. The results suggest that the prepared imaging tracer is a promising agent for tumor diagnosis.
d-
葡萄糖胺(DG)与一种核-交联聚合物胶束(CCPM)系统结合,该系统配备了近红外荧光
染料(NIRF)和γ发射体(111In)。所得到纳米尺度的肿瘤靶向成像示踪剂,111In-DG-NIRF-CCPM,在人上皮癌细胞癌A-431异种移植小鼠模型中选择性积累。注射后24小时,肿瘤摄取量为每克组织注射剂量的2.62 ± 0.80%(%ID/g)。肿瘤在单光子发射计算机断层扫描(
SPECT)和光学成像中都能清晰地描绘出来。结果表明,制备的成像示踪剂是一种有前途的肿瘤诊断剂。